Victoria A. Olson

9.5k total citations · 3 hit papers
77 papers, 4.7k citations indexed

About

Victoria A. Olson is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, Victoria A. Olson has authored 77 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Virology, 49 papers in Epidemiology and 40 papers in Molecular Biology. Recurrent topics in Victoria A. Olson's work include Poxvirus research and outbreaks (56 papers), Herpesvirus Infections and Treatments (45 papers) and Bacillus and Francisella bacterial research (35 papers). Victoria A. Olson is often cited by papers focused on Poxvirus research and outbreaks (56 papers), Herpesvirus Infections and Treatments (45 papers) and Bacillus and Francisella bacterial research (35 papers). Victoria A. Olson collaborates with scholars based in United States, Germany and Switzerland. Victoria A. Olson's co-authors include Inger K. Damon, Mary G. Reynolds, Darin S. Carroll, Russell L. Regnery, Kevin L. Karem, Yu Li, Yoshinori Nakazawa, Christine M. Hughes, Miriam T. Laker and Thomas M. Laue and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Virology.

In The Last Decade

Victoria A. Olson

76 papers receiving 4.5k citations

Hit Papers

The Detection of Monkeypox in Humans in the Western Hemis... 2004 2026 2011 2018 2004 2005 2018 200 400 600

Peers

Victoria A. Olson
Joseph J. Esposito United States
E. R. Tulman United States
Brett W. Petersen United States
M Szczeniowski Switzerland
Louis M. Mansky United States
Jerry P. Weir United States
Victoria A. Olson
Citations per year, relative to Victoria A. Olson Victoria A. Olson (= 1×) peers С. Н. Щелкунов

Countries citing papers authored by Victoria A. Olson

Since Specialization
Citations

This map shows the geographic impact of Victoria A. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria A. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria A. Olson more than expected).

Fields of papers citing papers by Victoria A. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria A. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria A. Olson. The network helps show where Victoria A. Olson may publish in the future.

Co-authorship network of co-authors of Victoria A. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria A. Olson. A scholar is included among the top collaborators of Victoria A. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria A. Olson. Victoria A. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Lauren E., Ashley V. Kondas, Claire Marie Filone, et al.. (2022). Identification of Small Molecules with Improved Potency against Orthopoxviruses from Vaccinia to Smallpox. Antimicrobial Agents and Chemotherapy. 66(11). e0084122–e0084122. 5 indexed citations
2.
Hutson, Christina L., Ashley V. Kondas, Jana M. Ritter, et al.. (2021). Teaching a new mouse old tricks: Humanized mice as an infection model for Variola virus. PLoS Pathogens. 17(9). e1009633–e1009633. 7 indexed citations
3.
Salzer, Johanna S., James A. Ellison, Ashley V. Kondas, et al.. (2019). Characterization of Monkeypox virus dissemination in the black-tailed prairie dog (Cynomys ludovicianus) through in vivo bioluminescent imaging. PLoS ONE. 14(9). e0222612–e0222612. 16 indexed citations
4.
Merchlinsky, Michael, et al.. (2019). The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox. Antiviral Research. 168. 168–174. 70 indexed citations
5.
Bansal, Amit, et al.. (2019). Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception. Nanomedicine Nanotechnology Biology and Medicine. 21. 102049–102049. 11 indexed citations
6.
Bansal, Amit, Xianfu Wu, Victoria A. Olson, & Martin J. D’Souza. (2018). Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel. International Journal of Pharmaceutics. 545(1-2). 318–328. 26 indexed citations
7.
Reed, Matthew S., Olga Stuchlik, William Carson, et al.. (2018). Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues. PLoS neglected tropical diseases. 12(12). e0006984–e0006984. 3 indexed citations
8.
Ananthula, Hari Krishna, Scott Parker, R. Mark L. Buller, et al.. (2018). Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC Pharmacology and Toxicology. 19(1). 80–80. 12 indexed citations
9.
Burgado, Jillybeth, L. Greenberg, Amrita Kumar, et al.. (2018). A high throughput neutralization test based on GFP expression by recombinant rabies virus. PLoS neglected tropical diseases. 12(12). e0007011–e0007011. 7 indexed citations
10.
Velasco-Villa, Andrés, Matthew R. Mauldin, Mǎng Shī, et al.. (2017). The history of rabies in the Western Hemisphere. Antiviral Research. 146. 221–232. 79 indexed citations
11.
Das, Sanchita, Mark S. Rundell, Aashiq H. Mirza, et al.. (2015). A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus. PLoS ONE. 10(9). e0138484–e0138484. 19 indexed citations
12.
Olson, Victoria A., Scott K. Smith, Scott A. Foster, et al.. (2014). In Vitro Efficacy of Brincidofovir against Variola Virus. Antimicrobial Agents and Chemotherapy. 58(9). 5570–5571. 47 indexed citations
13.
Mucker, Eric M., Arthur J. Goff, Joshua D. Shamblin, et al.. (2013). Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox). Antimicrobial Agents and Chemotherapy. 57(12). 6246–6253. 75 indexed citations
14.
Townsend, Michael B., Adam MacNeil, Mary G. Reynolds, et al.. (2012). Evaluation of the Tetracore Orthopox BioThreat® antigen detection assay using laboratory grown orthopoxviruses and rash illness clinical specimens. Journal of Virological Methods. 187(1). 37–42. 50 indexed citations
15.
Hudson, Paul, Joshua Self, Sonja Weiss, et al.. (2012). Elucidating the Role of the Complement Control Protein in Monkeypox Pathogenicity. PLoS ONE. 7(4). e35086–e35086. 65 indexed citations
16.
Gallardo‐Romero, Nadia, Clifton P. Drew, Sonja Weiss, et al.. (2012). The Pox in the North American Backyard: Volepox Virus Pathogenesis in California Mice (Peromyscus californicus). PLoS ONE. 7(8). e43881–e43881. 11 indexed citations
17.
Carroll, Darin S., Ginny L. Emerson, Yu Li, et al.. (2011). Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification. PLoS ONE. 6(8). e23086–e23086. 83 indexed citations
18.
Gallardo‐Romero, Nadia, Andrés Velasco-Villa, Sonja Weiss, et al.. (2011). Detection of North American orthopoxviruses by real time-PCR. Virology Journal. 8(1). 313–313. 3 indexed citations
19.
Peake, Lilian, Christopher Novak, R. M. Allen, et al.. (2009). Laboratory-acquired vaccinia virus infection - Virginia, 2008.. MMWR Morbidity and Mortality Weekly Report. 58(29). 797–800. 9 indexed citations
20.
Smith, Scott K., Victoria A. Olson, Kevin L. Karem, et al.. (2008). In Vitro Efficacy of ST246 against Smallpox and Monkeypox. Antimicrobial Agents and Chemotherapy. 53(3). 1007–1012. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026